bf/NASDAQ:HZNP_icon.png

COM:HORIZONTHERAPEUTICS

Horizon Therapeutics plc

  • Stock

USD

Last Close

116.30

14/11 21:00

Volume Today

23.92M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
7.63M
-
13.44M
76.10%
17.62M
31.06%
96.58M
448.12%
118.22M
22.41%
56.20M
52.46%
52.28M
6.99%
64.54M
23.46%
150.51M
133.19%
197.64M
31.32%
average payables
7.95M
-
15.47M
94.46%
18.80M
21.56%
34.53M
83.69%
43.58M
26.19%
32.48M
25.46%
25.90M
20.27%
29.61M
14.34%
33.92M
14.54%
92.96M
174.08%
average receivables
9.71M
-
44.94M
362.76%
142.18M
216.39%
258.08M
81.52%
336.54M
30.40%
416.04M
23.62%
436.71M
4.97%
534.19M
22.32%
646.24M
20.97%
654.56M
1.29%
book value per share
-0.77
-
6.45
936.56%
8.83
36.83%
7.86
10.89%
6.08
22.74%
6.34
4.42%
11.95
88.31%
19.74
65.19%
20.72
4.97%
22.14
6.87%
capex per share
-0.02
-
-0.04
122.06%
-0.05
15.09%
-0.10
103.54%
-0.03
72.86%
-0.10
279.90%
-0.10
3.29%
-0.98
903.75%
-0.56
42.91%
-0.55
1.47%
capex to depreciation
-0.13
-
-0.10
20.02%
-0.05
49.74%
-0.07
37.09%
-0.02
78.44%
-0.06
297.75%
-0.08
23.79%
-0.72
849.80%
-0.36
50.13%
-0.32
9.31%
capex to operating cash flow
0.02
-
-0.13
675.71%
-0.04
70.99%
-0.04
15.53%
-0.02
63.67%
-0.09
457.36%
-0.04
51.41%
-0.36
758.65%
-0.12
66.11%
-0.10
17.62%
capex to revenue
-0.02
-
-0.01
27.18%
-0.01
19.80%
-0.02
69.62%
-0.00
74.41%
-0.01
238.47%
-0.01
1.10%
-0.09
561.22%
-0.04
56.94%
-0.03
11.02%
cash per share
1.26
-
2.61
106.65%
5.78
121.14%
3.19
44.84%
4.65
45.78%
5.82
25.26%
5.95
2.30%
10.29
72.81%
7.12
30.75%
10.39
45.88%
days of inventory on hand
250.17
-
78.16
68.76%
30.56
60.91%
162.22
430.89%
41.20
74.61%
43.86
6.48%
54.22
23.62%
51.58
4.87%
103.70
101.03%
67.26
35.14%
days payables outstanding
247.60
-
97.38
60.67%
27.59
71.67%
48.71
76.56%
23.17
52.42%
26.17
12.95%
21.68
17.16%
25.84
19.17%
13.84
46.44%
61.80
346.54%
days sales outstanding
78.69
-
90.85
15.45%
101.46
11.68%
113.74
12.10%
126.94
11.61%
140.47
10.65%
114.74
18.31%
109.43
4.63%
71.59
34.58%
68.03
4.97%
debt to assets
0.44
-
0.30
30.56%
0.37
22.61%
0.42
12.79%
0.46
8.39%
0.46
0.21%
0.30
33.33%
0.17
45.82%
0.30
79.33%
0.28
5.10%
debt to equity
-2.26
-
0.64
128.34%
0.87
36.35%
1.43
64.01%
1.92
34.16%
1.80
6.23%
0.62
65.60%
0.25
59.73%
0.55
120.77%
0.51
8.18%
dividend yield
0.71
-
earnings yield
-0.31
-
-0.24
20.51%
0.01
105.02%
-0.06
623.32%
-0.17
168.65%
-0.02
86.74%
0.09
478.69%
0.03
69.81%
0.02
15.83%
0.02
9.05%
enterprise value
515.36M
-
1.21B
134.06%
3.51B
190.96%
3.90B
11.08%
3.53B
9.41%
4.18B
18.48%
6.90B
64.86%
13.84B
100.67%
25.30B
82.73%
26.28B
3.90%
enterprise value over ebitda
-15.36
-
84.55
650.32%
19.13
77.37%
26.45
38.26%
-32.59
223.20%
14.63
144.88%
18.46
26.17%
18.03
2.33%
27.83
54.37%
23.58
15.27%
ev to operating cash flow
-9.49
-
43.79
561.23%
18.08
58.72%
10.55
41.62%
12.60
19.45%
21.51
70.65%
16.18
24.77%
24.91
53.96%
24.43
1.92%
20.89
14.49%
ev to sales
6.96
-
4.06
41.66%
4.64
14.13%
3.97
14.29%
3.34
15.85%
3.47
3.63%
5.31
53.13%
6.29
18.56%
7.84
24.62%
7.24
7.63%
free cash flow per share
-0.87
-
0.29
132.94%
1.26
337.71%
2.20
75.13%
1.69
23.17%
1.07
36.74%
2.23
108.70%
1.74
21.87%
4.03
131.04%
4.94
22.54%
free cash flow yield
-0.11
-
0.02
119.48%
0.06
160.37%
0.14
134.55%
0.12
14.85%
0.05
52.73%
0.06
12.65%
0.02
61.34%
0.04
56.83%
0.04
16.03%
graham net net
-3.21
-
-3.72
16.03%
-4.89
31.30%
-13.69
180.05%
-12.94
5.46%
-10.54
18.54%
-4.53
57.05%
2.86
163.19%
-8.03
380.68%
-4.67
41.87%
graham number
6.37
-
21.37
235.39%
7.26
66.01%
13.55
86.60%
18.55
36.85%
7.98
56.96%
29.02
263.47%
29.13
0.39%
33.23
14.09%
33.67
1.32%
income quality
0.36
-
-0.10
128.69%
4.91
4,799.69%
-2.21
145.09%
-0.68
69.18%
-2.62
284.19%
0.74
128.37%
1.43
91.61%
1.94
35.87%
2.41
24.53%
intangibles to total assets
0.52
-
0.68
30.90%
0.63
7.09%
0.75
18.82%
0.69
7.96%
0.62
10.85%
0.48
22.48%
0.36
24.18%
0.57
56.32%
0.49
12.97%
interest coverage
-1.09
-
-0.36
67.42%
0.79
322.28%
-1.70
314.50%
-3.10
82.51%
0.02
100.63%
1.45
7,296.21%
8.22
465.39%
6.70
18.49%
7.38
10.09%
interest debt per share
2.36
-
4.41
87.22%
8.17
85.18%
11.79
44.34%
12.43
5.49%
12.15
2.30%
7.87
35.20%
5.21
33.79%
11.76
125.63%
11.55
1.77%
inventory turnover
1.46
-
4.67
220.06%
11.95
155.80%
2.25
81.16%
8.86
293.79%
8.32
6.08%
6.73
19.10%
7.08
5.11%
3.52
50.26%
5.43
54.19%
invested capital
-2.26
-
0.64
128.34%
0.87
36.35%
1.43
64.01%
1.92
34.16%
1.80
6.23%
0.62
65.60%
0.25
59.73%
0.55
120.77%
0.51
8.18%
market cap
485.07M
-
1.08B
122.55%
3.22B
198.66%
2.60B
19.36%
2.38B
8.40%
3.25B
36.32%
6.62B
103.96%
14.92B
125.31%
24.31B
62.90%
26.07B
7.27%
net current asset value
-190.91M
-
-268.19M
40.48%
-647.65M
141.49%
-1.98B
206.03%
-1.94B
1.88%
-1.54B
20.62%
-564.48M
63.44%
1.02B
281.25%
-1.21B
217.83%
-389.60M
67.68%
net debt to ebitda
-0.90
-
8.88
1,083.70%
1.56
82.47%
8.81
466.07%
-10.61
220.47%
3.28
130.89%
0.74
77.43%
-1.40
289.46%
1.09
177.76%
0.19
82.72%
net income per share
-2.34
-
-3.15
34.47%
0.27
108.44%
-1.04
490.74%
-2.52
142.41%
-0.45
82.26%
3.13
801.57%
1.91
38.99%
2.37
24.00%
2.28
3.95%
operating cash flow per share
-0.85
-
0.33
138.57%
1.30
296.73%
2.30
76.17%
1.72
25.28%
1.17
31.84%
2.33
99.05%
2.72
16.90%
4.59
68.48%
5.49
19.61%
payables turnover
1.47
-
3.75
154.26%
13.23
253.00%
7.49
43.36%
15.75
110.19%
13.95
11.47%
16.83
20.72%
14.13
16.09%
26.37
86.70%
5.91
77.61%
receivables turnover
4.64
-
4.02
13.38%
3.60
10.46%
3.21
10.79%
2.88
10.40%
2.60
9.63%
3.18
22.42%
3.34
4.86%
5.10
52.87%
5.37
5.23%
research and ddevelopement to revenue
0.14
-
0.06
56.84%
0.06
5.95%
0.06
11.89%
0.21
244.22%
0.07
67.82%
0.08
15.79%
0.10
19.89%
0.13
40.72%
0.12
9.87%
return on tangible assets
-1.23
-
-0.72
40.91%
0.03
104.82%
-0.16
544.83%
-0.32
104.64%
-0.05
85.38%
0.25
630.99%
0.10
59.29%
0.14
40.94%
0.11
20.53%
revenue per share
1.16
-
3.55
204.95%
5.09
43.50%
6.11
19.99%
6.48
6.06%
7.27
12.24%
7.11
2.22%
10.79
51.80%
14.30
32.59%
15.84
10.73%
roe
3.04
-
-0.49
116.07%
0.03
106.17%
-0.13
538.51%
-0.41
213.77%
-0.07
83.01%
0.26
472.57%
0.10
63.07%
0.11
18.13%
0.10
10.12%
roic
-0.69
-
-0.01
98.64%
-0.01
28.40%
-0.04
422.37%
-0.11
209.52%
0.00
100.47%
-1.01
200,970.90%
0.09
109.33%
0.09
8.44%
0.08
7.58%
sales general and administrative to revenue
0.32
-
0.30
5.91%
0.29
3.05%
0.29
1.05%
0.42
-
shareholders equity per share
-0.77
-
6.45
936.56%
8.83
36.83%
7.86
10.89%
6.08
22.74%
6.34
4.42%
11.95
88.31%
19.74
65.19%
20.72
4.97%
22.14
6.87%
stock based compensation to revenue
0.07
-
0.04
34.39%
0.11
148.33%
0.12
4.37%
0.12
2.75%
0.10
19.64%
0.07
26.23%
0.07
5.03%
0.07
1.90%
0.05
26.10%
tangible asset value
-180.18M
-
-230.63M
28.00%
-622.78M
170.03%
-1.96B
213.95%
-1.88B
3.61%
-1.50B
20.55%
69.15M
104.62%
1.83B
2,544.49%
-234.43M
112.82%
586.86M
350.33%
tangible book value per share
-2.83
-
-2.75
2.71%
-4.19
52.00%
-12.17
190.68%
-11.55
5.04%
-9.01
22.00%
0.38
104.19%
8.97
2,271.74%
-1.04
111.59%
2.56
346.44%
working capital
67.45M
-
106.83M
58.38%
748.60M
600.72%
440.43M
41.17%
473.20M
7.44%
786.52M
66.21%
962.93M
22.43%
2.19B
127.91%
1.91B
12.83%
2.70B
41.32%

All numbers in USD (except ratios and percentages)